InvestorsHub Logo
icon url

vanwes1

05/26/17 11:18 AM

#258401 RE: mrwrn2010 #258398

Honestly most bioequivalence trials don't have problems with recruitment. This isn't a clinical phase 3 trial requiring millions of individuals. How hard is it to find healthy individuals who can take a drug and then compare their serum to individuals who took a controlled substance and determine if the study drug is bioequivalent. It's the first step in FDA approval. Every drug has to go through this. And now Elite has a delay at the lowest level of evidence.
icon url

dr_lowenstein

05/26/17 11:31 AM

#258406 RE: mrwrn2010 #258398

because it is not true there were zero adverse events during the bunion trial